🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2, Multi-Cohort, Open-Label, Multi-Center Study. Cohort 1 w...
Status
Unknown
Location
University of Arizona
Start Date
2018-10-11
Trial ID
NCT03567720
Treatments Being Tested
This phase II trial studies the effectiveness of ImmunoPulse IL-12® in trea...
Status
Completed
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2012-01-03
Trial ID
NCT01440816
Treatments Being Tested
Keynote 695 is Phase 2 study of intratumoral tavokinogene telseplasmid (tav...
Status
Unknown
Location
The University of Arizona Cancer Center
Start Date
2017-10-03
Trial ID
NCT03132675
Treatments Being Tested
This is a Phase 1, open-label study to evaluate the safety profile of CORVa...
Status
Terminated
Location
Providence Portland Medical Center
Start Date
2020-12-30
Trial ID
NCT04627675
Treatments Being Tested
This phase II trial studies how well tavokinogene telseplasmid with electro...
Status
Terminated
Location
University of California, San Francisco
Start Date
2019-05-02
Trial ID
NCT03823131
Treatments Being Tested
This is a Phase 2 open-label, single-arm study of neoadjuvant treatment of ...
Status
Completed
Location
Moffitt Cancer Center
Start Date
2020-12-22
Trial ID
NCT04526730
Treatments Being Tested
This study will assess the safety and effectiveness of ImmunoPulse IL-12® i...
Status
Terminated
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2015-05-21
Trial ID
NCT02345330
Treatments Being Tested
This study will assess the safety and effectiveness of different dosing reg...
Status
Completed
Location
UCSF Helen Diller Comprehensive Cancer Center
Start Date
2012-02-14
Trial ID
NCT01502293
Treatments Being Tested
A single arm, open label, multi-center, phase 2 study to assess the safety ...
Status
Terminated
Location
UCSF Helen Diller Comprehensive Cancer Center
Start Date
2012-06-08
Trial ID
NCT01579318
Treatments Being Tested